Glenmark Pharmaceuticals LimitedNSE: GLENMARK

Press Release May 17 2024

· Issued by Glenmark Pharmaceuticals Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-may-17-2024-8

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated May 17, 2024, titled "Glenmark Pharmaceuticals receives ANDA approval for Brimonidine Tartrate and Timolol Maleate Opthalmic Solution, 0.2% / 0.5%".

View Attachment

6ix hasn’t read this filing yet.

Glenmark Pharmaceuticals Limited on 6ix

Earlier from Glenmark Pharmaceuticals

Later from Glenmark Pharmaceuticals

All Glenmark Pharmaceuticals news releases